Investing-News.Com
Information for Investors

NOVARTIS AG ADS, (NVS) Stock Ratings - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   

 

NOVARTIS AG ADS, (NVS) Stock Rating Learn More

Our Overall Rating on Novartis AG,  NVS is BUY
StockPickReport.Com research suggests NVS's price will move significantly higher than the "open price" the day this rating was initiated.

This analysis is based on short-term stochastic and "relative strength" indicators.

Both stochastic and "relative strength" indicators point to a move up.

Investors, traders, and other market participants may find this a good opportunity to buy NVS, "buy calls", or "sell puts".

This may also be an opportunity to raise targets and stop/losses to allow for potential gains.

Trading volume seems to be falling and NVS's closing price moved up during the week before this rating was initiated.

Our BUY Rating on NVS was issued on 03/25/08

NOVARTIS AG ADS Technical Rating



Ratings Provided by Stock-Letter-Daily.Com

Rate Any Stock
(enter symbol and click)

Stock Rating Definitions

Stock Ratings Home

Sponsored Links:

Software Forces NOVARTIS AG ADS Investors To Buy Low and Sell High The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors in NOVARTIS AG ADS buy low and sell high every time guaranteed. Click Here To Learn More

We Give Precision Entry & Exit Points on NOVARTIS AG ADS. This software is specially designed to give precision entry and exit points on NOVARTIS AG ADS, or any other stock you choose.
Click Here to learn how to take control of your trading.

How To Know When NOVARTIS AG ADS Beats The Street. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum. Maybe even NOVARTIS AG ADS, if they make the cut.
Click Here & Learn To
Pick Winners In An Uncertain Market



Related Searches: automatic forex system trading  stock split chart  stockwatch  the dines letter 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

Manufacturing Pain (at Motley Fool)

ADR Report-Bargain hunting lifts ADRs but drugs slide (at Reuters)

[$$] Three-Day Skid for European Stocks (at The Wall Street Journal Online)

Europe Markets: Pharmaceuticals slide as stocks in Europe turned mixed (at MarketWatch)

European regulator rejects Bristol-Myers breast cancer drug (at MarketWatch)

[$$] Novartis Says Research Shift Has Bolstered Drug Pipeline (at The Wall Street Journal Online)

Pharmas and Biotech: Vying for Outsize Insulin Profits (at Seeking Alpha)

Sanofi Cuts Deal In Legal Battle And Redeploys (at Forbes.com)

Novartis: New research strategies paying off (AP)

International pharma group names leadership (AP)

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.